tiprankstipranks
Advertisement
Advertisement

KALV Stock Latest News

KalVista presents new data on injectable on-demand treatment in children
The FlyKalVista presents new data on injectable on-demand treatment in children
4d ago
KALV
Merger Agreement With Chiesi Puts Strategic Handcuffs on KalVista, Raising Execution and Liquidity Risks
PremiumCompany Announcements
Merger Agreement With Chiesi Puts Strategic Handcuffs on KalVista, Raising Execution and Liquidity Risks
16d ago
KALV
KalVista downgraded to Hold from Buy at Stifel
PremiumThe Fly
KalVista downgraded to Hold from Buy at Stifel
25d ago
KALV
KalVista downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
KalVista downgraded to Neutral from Buy at H.C. Wainwright
1M ago
KALV
KalVista downgraded to Hold from Buy at Needham
PremiumThe Fly
KalVista downgraded to Hold from Buy at Needham
1M ago
KALV
KalVista downgraded to Hold from Buy at JonesResearch
PremiumThe FlyKalVista downgraded to Hold from Buy at JonesResearch
1M ago
KALV
KalVista Downgraded to $27 Target as Chiesi’s All-Cash Takeout Caps Near-Term Upside, Supporting Hold Rating
Premium
Ratings
KalVista Downgraded to $27 Target as Chiesi’s All-Cash Takeout Caps Near-Term Upside, Supporting Hold Rating
1M ago
KALV
KalVista downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
KalVista downgraded to Market Perform from Outperform at Leerink
1M ago
KALV
KalVista downgraded to Market Perform from Outperform at Citizens
PremiumThe Fly
KalVista downgraded to Market Perform from Outperform at Citizens
1M ago
KALV
KalVista moved to No Rating at BofA
PremiumThe Fly
KalVista moved to No Rating at BofA
1M ago
KALV
Midday Fly By: Seagate reports Q3 beat, Visa reports mixed Q2
PremiumThe Fly
Midday Fly By: Seagate reports Q3 beat, Visa reports mixed Q2
1M ago
V
BE
Chiesi to Acquire KalVista Pharmaceuticals in Cash Merger
PremiumCompany Announcements
Chiesi to Acquire KalVista Pharmaceuticals in Cash Merger
1M ago
8K
KALV
Chiesi Group to acquire KalVista for $27.00 per share in cash
PremiumThe FlyChiesi Group to acquire KalVista for $27.00 per share in cash
1M ago
KALV
3 ‘Strong Buy’ Stocks With Up to 180% Upside to Buy Now, According to Top Analysts, 4/16/2026
Premium
Market News
3 ‘Strong Buy’ Stocks With Up to 180% Upside to Buy Now, According to Top Analysts, 4/16/2026
2M ago
ACRS
KALV
Ekterly: Strong Global Launch Momentum and Pediatric Upside Support Multi‑Year Growth and $39 Price Target
Premium
Ratings
Ekterly: Strong Global Launch Momentum and Pediatric Upside Support Multi‑Year Growth and $39 Price Target
2M ago
KALV
KalVista announces interim Phase 3 data from KONFIDENT-KID trial of EKTERLY
PremiumThe Fly
KalVista announces interim Phase 3 data from KONFIDENT-KID trial of EKTERLY
2M ago
KALV
Sustained EKTERLY Uptake and Shift Toward Oral HAE Therapy Underpin Buy Rating on KalVista
PremiumRatings
Sustained EKTERLY Uptake and Shift Toward Oral HAE Therapy Underpin Buy Rating on KalVista
2M ago
KALV
KalVista price target lowered to $28 from $29 at Citizens
PremiumThe Fly
KalVista price target lowered to $28 from $29 at Citizens
2M ago
KALV
KalVista price target raised to $42 from $39 at Stifel
PremiumThe Fly
KalVista price target raised to $42 from $39 at Stifel
2M ago
KALV
KalVista reports 8M EPS ($2.03) vs. ($2.30) last year
PremiumThe FlyKalVista reports 8M EPS ($2.03) vs. ($2.30) last year
2M ago
KALV
KalVista sees cash runway through profitability
Premium
The Fly
KalVista sees cash runway through profitability
2M ago
KALV
Early Outperformance and Expanding On‑Demand HAE Opportunity Justify Buy Rating on KalVista
Premium
Ratings
Early Outperformance and Expanding On‑Demand HAE Opportunity Justify Buy Rating on KalVista
3M ago
KALV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >